Latest Breaking News On - Dayoon kim - Page 1 : comparemela.com

GPCR Therapeutics Announces Out-Licensing Agreement with Bridge Biotherapeutics in Idiopathic Pulmonary Fibrosis

GPCR Therapeutics Announces Out-Licensing Agreement with Bridge Biotherapeutics in Idiopathic Pulmonary Fibrosis
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomUnited statesSoult ukpyolsiSouth koreaRepublic of koreaDaniel goochDayoon kimJames leeAmerican lung associationTherapeutics incBridge biotherapeutics incBusiness developmentScius communicationsBiotherapeutics incAnnounces out licensing agreement

GPCR Therapeutics Announces Publication on Improving Hematopoietic Stem Cell Mobilization Using Propranolol with GPC-100

GPCR Therapeutics Announces Publication on Improving Hematopoietic Stem Cell Mobilization Using Propranolol with GPC-100
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSoult ukpyolsiSouth koreaDayoon kimTherapeutics incInstitute of microbiologyBusiness development managertelSeoul national universitySeoul national university school of biological sciencesBiological sciencesDong seung seenAutologous stem cell transplantSan francisco bay areaDevelopment managertel

GPCR Therapeutics Expands Pipeline into Fibrosis with a Combination Approach Targeting LPA1

GPCR Therapeutics Expands Pipeline into Fibrosis with a Combination Approach Targeting LPA1
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Soult ukpyolsiSouth koreaUnited statesCity ofUnited kingdomDayoon kimDaniel goochPina cardarelliInstitute of microbiologySeoul national university school of biological sciencesScius communicationsBusiness developmentTherapeutics incExpands pipelineCombination approach targetingCell communication

GPCR Therapeutics Expands Scientific Advisory Board

GPCR just had a very successful first meeting including all the Scientific Advisory Board.

Soult ukpyolsiSouth koreaUnited statesDayoon kimLuisa salter cidBristol myers squibbSutro biopharmaOmar nadeemJon wiggintonMichel bouvierRobertj lefkowitzUniversity of lisbonNational cancer instituteRoss universityInstitute for researchMerck co